Literature DB >> 30739718

Corrigendum to "EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma" [J Hepatol 69 (2018) 182-236].

.   

Abstract

Entities:  

Year:  2019        PMID： 30739718     DOI： 10.1016/j.jhep.2019.01.020

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  11 in total

1.  Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma.

Authors:  Jihane N Benhammou; Jonathan Lin; Shehnaz K Hussain; Mohamed El-Kabany
Journal:  Hepatoma Res       Date:  2020-06-18

2.  Texture Analysis Based on Gd-EOB-DTPA-Enhanced MRI for Identifying Vessels Encapsulating Tumor Clusters (VETC)-Positive Hepatocellular Carcinoma.

Authors:  Yanfen Fan; Yixing Yu; Ximing Wang; Mengjie Hu; Mingzhan Du; Lingchuan Guo; Shifang Sun; Chunhong Hu
Journal:  J Hepatocell Carcinoma       Date:  2021-05-05

3.  Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression Network.

Authors:  Wanbang Zhou; Yiyang Chen; Ruixing Luo; Zifan Li; Guanwei Jiang; Xi Ou
Journal:  Pathol Oncol Res       Date:  2021-04-02       Impact factor: 3.201

4.  Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib.

Authors:  Tao Sun; Yanqiao Ren; Xuefeng Kan; Lei Chen; Weihua Zhang; Fan Yang; Chuansheng Zheng
Journal:  Front Mol Biosci       Date:  2020-12-04

5.  The semi-erect position for better visualization of subphrenic hepatocellular carcinoma during ultrasonography examinations.

Authors:  Seong Eun Ko; Min Woo Lee; Hyo Keun Lim; Ji Hye Min; Dong Ik Cha; Tae Wook Kang; Kyoung Doo Song; Min Ju Kim; Hyunchul Rhim
Journal:  Ultrasonography       Date:  2020-06-22

6.  A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma.

Authors:  Jonggi Choi; So-Hyun Kim; Seungbong Han; Danbi Lee; Ju Hyun Shim; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Sung-Gyu Lee; Ki-Hun Kim; Kang Mo Kim
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

7.  ALDH2 genotype modulates the association between alcohol consumption and AST/ALT ratio among middle-aged Japanese men: a genome-wide G × E interaction analysis.

Authors:  Yoichi Sutoh; Tsuyoshi Hachiya; Yuji Suzuki; Shohei Komaki; Hideki Ohmomo; Keisuke Kakisaka; Ting Wang; Yasuhiro Takikawa; Atsushi Shimizu
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

8.  Cancer stage at presentation for incarcerated patients at a single urban tertiary care center.

Authors:  Kathryn I Sunthankar; Kevin N Griffith; Stephanie D Talutis; Amy K Rosen; David B McAneny; Matthew H Kulke; Jennifer F Tseng; Teviah E Sachs
Journal:  PLoS One       Date:  2020-09-15       Impact factor: 3.240

9.  Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib.

Authors:  Ajalaya Teyateeti; Armeen Mahvash; James Long; Mohamed Abdelsalam; Rony Avritscher; Ahmed Kaseb; Bruno Odisio; Gregory Ravizzini; Devaki Surasi; Achiraya Teyateeti; Homer Macapinlac; Srinivas Cheenu Kappadath
Journal:  World J Gastroenterol       Date:  2021-12-21       Impact factor: 5.742

10.  First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study.

Authors:  Shigeo Shimose; Atsushi Hiraoka; Masahito Nakano; Hideki Iwamoto; Masatoshi Tanaka; Takaaki Tanaka; Kazunori Noguchi; Hajime Aino; Kei Ogata; Masahiko Kajiwara; Satoshi Itano; Yoshinori Yokokura; Taizo Yamaguchi; Hiroshi Kawano; Norito Matsukuma; Hideya Suga; Takashi Niizeki; Tomotake Shirono; Yu Noda; Naoki Kamachi; Shusuke Okamura; Takumi Kawaguchi; Hironori Koga; Takuji Torimura
Journal:  Cancer Med       Date:  2021-10-24       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.